ORCID Profile
0000-0003-3915-7243
Current Organisations
Cardiff University
,
Royal College of Radiologists
,
University of Nottingham
,
Royal College of Physicians
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Related Links
Publications
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
Publisher: Elsevier BV
Date: 11-2019
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publisher: Elsevier BV
Date: 02-2021
CRIB—the use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial (RCT) with embedded feasibility study
Publisher: BMJ
Date: 02-2014
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Publisher: Elsevier BV
Date: 05-2021
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk
Publisher: Springer Science and Business Media LLC
Date: 27-05-2012
DOI: 10.1038/NG.2293
Dexamethasone in Hospitalized Patients with Covid-19
Publisher: Massachusetts Medical Society
Date: 25-02-2021
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project
Publisher: Oxford University Press (OUP)
Date: 18-12-2017
DOI: 10.1093/JNCI/DJX253
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Publisher: Massachusetts Medical Society
Date: 19-07-2100
Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer
Publisher: BMJ
Date: 12-12-2017
DOI: 10.1136/GUTJNL-2017-315333
Abstract: Colorectal cancer (CRC) leads to significant morbidity/mortality worldwide. Defining critical research gaps (RG), their prioritisation and resolution, could improve patient outcomes. RG analysis was conducted by a multidisciplinary panel of patients, clinicians and researchers (n=71). Eight working groups (WG) were constituted: discovery science risk prevention early diagnosis and screening pathology curative treatment stage IV disease and living with and beyond CRC. A series of discussions led to development of draft papers by each WG, which were evaluated by a 20-strong patient panel. A final list of RGs and research recommendations (RR) was endorsed by all participants. Fifteen critical RGs are summarised below: RG1 : Lack of realistic models that recapitulate tumour/tumour micro/macroenvironment RG2 : Insufficient evidence on precise contributions of genetic/environmental/lifestyle factors to CRC risk RG3 : Pressing need for prevention trials RG4 : Lack of integration of different prevention approaches RG5 : Lack of optimal strategies for CRC screening RG6 : Lack of effective triage systems for invasive investigations RG7 : Imprecise pathological assessment of CRC RG8 : Lack of qualified personnel in genomics, data sciences and digital pathology RG9 : Inadequate assessment/communication of risk, benefit and uncertainty of treatment choices RG10 : Need for novel technologies/interventions to improve curative outcomes RG11 : Lack of approaches that recognise molecular interplay between metastasising tumours and their microenvironment RG12 : Lack of reliable biomarkers to guide stage IV treatment RG13 : Need to increase understanding of health related quality of life (HRQOL) and promote residual symptom resolution RG14 : Lack of coordination of CRC research/funding RG15 : Lack of effective communication between relevant stakeholders. Prioritising research activity and funding could have a significant impact on reducing CRC disease burden over the next 5 years.
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publisher: Elsevier BV
Date: 05-2021
Related Organisations
Cardiff University
Location: United Kingdom of Great Britain and Northern Ireland
Royal College Of Radiologists
Location: United Kingdom of Great Britain and Northern Ireland
University Of Nottingham
Location: United Kingdom of Great Britain and Northern Ireland
Royal College Of Physicians
Location: United Kingdom of Great Britain and Northern Ireland
Related Funding Activities
No related grants have been discovered for Richard Adams.